NCT00004811View on ClinicalTrials.gov

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

March 31, 1985

Conditions

HistoplasmosisSporotrichosisBlastomycosis

Interventions

DRUG

itraconazole

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

University of Alabama at Birmingham

OTHER

lead

National Center for Research Resources (NCRR)

NIH